Microglial cell surface

The microglial cell surface refers to the complex plasma membrane of the resident macrophages of the central nervous system (CNS). This interface is densely populated with a variety of receptors, including pattern recognition receptors (PRRs), purinergic receptors, and cytokine/chemokine receptors, which collectively enable microglia to monitor the CNS microenvironment (Nimmerjahn et al., 2005, Science). These surface molecules play pivotal roles in maintaining brain homeostasis through functions such as phagocytosis of debris, synaptic pruning, and the initiation of immune responses (Colonna & Butovsky, 2017, Nature Reviews Immunology). In pathological states like Alzheimer's disease, specific surface proteins such as TREM2 and CD33 are significantly involved in the disease's progression and have become major focal points for drug development (Deczkowska et al., 2020, Cell). Therapeutic strategies often involve monoclonal antibodies or small molecules designed to bind these surface receptors to shift microglia from a neurotoxic to a neuroprotective phenotype (Hickman et al., 2018, Nature Neuroscience). However, because the microglial cell surface is a cellular compartment containing hundreds of distinct molecular entities, it is categorized as a site of action rather than a single discrete therapeutic target.

Other names

Microglial plasma membraneMicroglial surface receptorsMicroglial membrane

Drugs interacting with the microglial cell surface typically function by modulating specific membrane-bound receptors to alter microglial polarization, enhance phagocytic clearance of pathological proteins, or inhibit the release of pro-inflammatory cytokines (Hickman et al., 2018, Nature Neuroscience).